Cumberland Pharmaceuticals Company Profile (NASDAQ:CPIX)

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals logoCumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: CPIX
  • CUSIP: 23077010
Key Metrics:
  • Previous Close: $4.45
  • 50 Day Moving Average: $4.64
  • 200 Day Moving Average: $4.61
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $72.20M
  • Outstanding Shares: 16,225,000
  • Beta: 1.08
Additional Links:
Companies Related to Cumberland Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Cumberland Pharmaceuticals (NASDAQ:CPIX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No equities research coverage for this company has been tracked by


Earnings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$0.04$8.90 million$7.40 millionViewN/AView Earnings Details
5/10/2016Q116$0.02$8.70 million$7.70 millionViewListenView Earnings Details
3/3/2016Q415$0.03$29.93 million$8.04 millionViewN/AView Earnings Details
11/3/2015Q315$0.04$29.93 million$7.90 millionViewN/AView Earnings Details
8/4/2015Q215$0.09$29.93 million$8.90 millionViewN/AView Earnings Details
5/7/2015Q115$0.09$8.10 million$8.70 millionViewN/AView Earnings Details
3/3/2015Q414$0.10$8.05 million$9.30 millionViewN/AView Earnings Details
5/13/2014Q114$0.02$10.26 million$8.09 millionViewN/AView Earnings Details
3/4/2014Q4 13$0.05($0.08)ViewN/AView Earnings Details
11/5/2013Q313($0.04)$7.60 million$6.50 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.02($0.03)$9.40 million$7.10 millionViewN/AView Earnings Details
5/2/2013Q113$0.05$0.05$10.00 million$10.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$0.14$0.09$13.87 million$13.70 millionViewN/AView Earnings Details
11/1/2012Q312$0.09$0.10$13.05 million$12.50 millionViewN/AView Earnings Details
8/2/2012$0.07$0.09ViewN/AView Earnings Details
5/3/2012$0.05$0.02ViewN/AView Earnings Details
2/29/2012$0.05$0.04ViewN/AView Earnings Details
11/3/2011$0.06$0.09ViewN/AView Earnings Details
8/4/2011$0.04$0.11ViewN/AView Earnings Details
5/5/2011$0.03$0.03ViewN/AView Earnings Details
3/8/2011$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No earnings estimates for this company have been tracked by


Dividend History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2016Thomas R LawrenceDirectorSell3,000$4.60$13,800.00View SEC Filing  
5/26/2016Thomas R LawrenceDirectorSell3,000$4.55$13,650.00View SEC Filing  
11/19/2015Thomas R LawrenceDirectorSell4,000$5.61$22,440.00View SEC Filing  
3/19/2015Thomas R LawrenceDirectorSell6,000$6.95$41,700.00View SEC Filing  
11/20/2014Thomas R LawrenceDirectorSell10,000$5.12$51,200.00View SEC Filing  
8/21/2014Thomas R LawrenceDirectorSell15,000$5.08$76,200.00View SEC Filing  
3/19/2014Thomas LawrenceDirectorSell20,000$4.54$90,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cumberland Pharmaceuticals (NASDAQ:CPIX)
DateHeadline logoCumberland Pharmaceuticals (CPIX) Commences Shipments of Ethyol to U.S. Wholesalers (NASDAQ:CPIX) - August 24 at 9:37 AM
News IconDirector of Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), Lawrence Thomas R, sells 3,000 shares worth $13,800 (NASDAQ:CPIX) - August 20 at 4:24 PM logoNew Study: Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic SWOT Analysis Review (NASDAQ:CPIX) - August 19 at 3:28 PM logoETF’s with exposure to Cumberland Pharmaceuticals, Inc. : August 11, 2016 (NASDAQ:CPIX) - August 11 at 4:28 PM logoCumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:CPIX) - August 9 at 5:23 PM logoCumberland posts 2Q loss (NASDAQ:CPIX) - August 2 at 9:56 PM logoCumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results (NASDAQ:CPIX) - August 2 at 4:29 PM logoCumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results (NASDAQ:CPIX) - August 2 at 4:29 PM logoQ2 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CPIX) - August 2 at 9:12 AM logoCumberland Pharmaceuticals To Announce Second Quarter 2016 Financial Results (NASDAQ:CPIX) - July 26 at 4:18 PM logoETF’s with exposure to Cumberland Pharmaceuticals, Inc. : July 20, 2016 (NASDAQ:CPIX) - July 20 at 12:17 PM logoShares Trading unchanged at $4.65 Cumberland Pharmaceuticals To… (NASDAQ:CPIX) - July 19 at 10:36 AM logoCumberland Pharmaceuticals To Participate In Avondale Partners' 4th Annual Healthcare Conference (NASDAQ:CPIX) - July 18 at 9:00 AM logoCumberland Pharmaceuticals Announces Caroline Young To Join Its Board Of Directors (NASDAQ:CPIX) - June 10 at 8:19 AM
News IconLawrence Thomas R, Director of Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) sells 3,000 shares (NASDAQ:CPIX) - May 28 at 6:57 AM logoCumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CPIX) - May 17 at 2:21 PM logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:CPIX) - May 13 at 4:59 PM logoEdited Transcript of CPIX earnings conference call or presentation 10-May-16 8:30pm GMT (NASDAQ:CPIX) - May 10 at 6:33 PM logoCumberland reports 1Q loss (NASDAQ:CPIX) - May 10 at 5:36 PM logoCumberland Pharmaceuticals Reports First Quarter 2016 Financial Results (NASDAQ:CPIX) - May 10 at 4:18 PM logoQ1 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CPIX) - May 10 at 7:07 AM logoCumberland Pharmaceuticals To Announce First Quarter 2016 Financial Results (NASDAQ:CPIX) - May 3 at 4:40 PM
News IconCumberland Pharmaceuticals Inc (CPIX): Ariel Investments Snapping Up Shares (NASDAQ:CPIX) - April 8 at 10:41 AM logoCumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2015 Financial Results (NASDAQ:CPIX) - February 25 at 4:05 PM logoVaprisol Dose Comparison Published Supporting Its Efficacy, Safety And Pharmacokinetics (NASDAQ:CPIX) - February 10 at 8:30 AM logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CPIX) - February 1 at 6:13 AM logoPiramal Critical Care And Cumberland Pharmaceuticals Announce Launch Of Caldolor And Vaprisol Co-Promotion (NASDAQ:CPIX) - January 25 at 8:27 AM logoCumberland Pharmaceuticals, Inc. (CPIX) (NASDAQ:CPIX) - January 17 at 8:05 PM logoCumberland Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:CPIX) - December 21 at 12:23 PM logoCUMBERLAND PHARMACEUTICALS INC Financials (NASDAQ:CPIX) - December 8 at 1:17 PM logoCumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing (NASDAQ:CPIX) - December 7 at 8:30 AM logoCumberland Pharmaceuticals to Webcast, Live, at December 3 (NASDAQ:CPIX) - November 30 at 9:05 AM logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events (NASDAQ:CPIX) - November 24 at 5:23 PM logoCaldolor® Launched In Australia For Treatment Of Pain And Fever (NASDAQ:CPIX) - November 23 at 4:20 PM logoCaldolor Approved For Use In Pediatric Patients (NASDAQ:CPIX) - November 23 at 9:20 AM


Cumberland Pharmaceuticals (NASDAQ:CPIX) Chart for Sunday, August, 28, 2016

Last Updated on 8/28/2016 by Staff